High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C.

被引：0
|
作者：
Kaiser, S [1 ]
Hass, H [1 ]
Gregor, M [1 ]
机构：
[1] Univ Tubingen Hosp, Tubingen, Germany
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
796
引用
收藏
页码：362A / 362A
页数：1
相关论文
共 50 条
  • [31] Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, N
    Jeffries, MA
    Schutz, SM
    Matossian, H
    Jolley, JJ
    Sheinbaum, AJ
    Meadows, JG
    GASTROENTEROLOGY, 2000, 118 (04) : A1461 - A1461
  • [32] Successful retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
    Kaiser, S
    Hass, H
    Gregor, M
    GASTROENTEROLOGY, 2004, 126 (04) : A668 - A668
  • [33] Successful Retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
    Kaiser, S
    Hass, H
    Gregor, M
    GASTROENTEROLOGY, 2003, 124 (04) : A700 - A700
  • [34] High dose induction interferon therapy followed by combination therapy with ribavirin for hepatitis C non-responders.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Domschke, W
    Menzel, M
    Gregor, M
    GASTROENTEROLOGY, 2000, 118 (04) : A950 - A950
  • [35] Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy
    Steindl-Munda, P
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Gangl, A
    Vogel, W
    LIVER INTERNATIONAL, 2003, 23 (04) : 269 - 275
  • [36] Induction treatment with high dose interferon alpha combined with ribavirin and amantadine for treatment naive patients with chronic hepatitis C a 2 arm randomised pilot study.
    Sentjens, R
    Beld, M
    Weegink, C
    Reesink, H
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [37] Interferon alfa-2b and ribavirin in treatment-naive patients with chronic hepatitis C and normal ALT levels
    Jacobson, I
    Lebovics, E
    Tobias, H
    Geders, J
    Klion, F
    Esposito, S
    GASTROENTEROLOGY, 1999, 116 (04) : A1225 - A1225
  • [38] Treatment of therapy naive hepatitis C patients with combination of interferon/ribavirin: Does efficacy translate into effectiveness?.
    Shehab, TM
    Kherbek, M
    Fontana, RJ
    Olberhelman, K
    Marrero, JA
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 337A - 337A
  • [39] High sustained response to daily dosing of interferon with ribavirin in chronic hepatitis C patients naive to therapy
    Abbas, Z
    Hamid, S
    Tabassum, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (05) : 577 - 581
  • [40] High dose interferon with ribavirin or iron reduction for interferon-resistant chronic hepatitis C.
    Kugelmas, M
    Vivian, B
    Antle, A
    Marsano-Obando, L
    GASTROENTEROLOGY, 1999, 116 (04) : A1234 - A1234
12345